{"date":"2025-12-02","count":18,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4745-2025-12-02-2200-1kns04z","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-02","time":"22:00:28","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告召開2025年第二次臨時股東會相關事宜","clause":"第17款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-12-02 22:00，「代重要子公司合富（中國）醫療科技股份有限公司公告召開2025年第二次臨時股東會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-12-02-2200-g0mtjm","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-02","time":"22:00:12","subject":"代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案","clause":"第53款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-12-02 22:00，「代重要子公司合富（中國）醫療科技股份有限公司公告董事會通過各項議案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-12-02-1826-9dpsv1","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"18:26:42","subject":"本公司受邀參加富邦證券主辦之「2025富邦生技產業企業日」","clause":"第30款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-12-02 18:26，「本公司受邀參加富邦證券主辦之「2025富邦生技產業企業日」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6932-2025-12-02-1804-bfwm5b","company_id":"6932","company":"水星生醫*","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"18:04:41","subject":"公告本公司第二次實施庫藏股期間屆滿及執行情形","clause":"第41款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：水星生醫*（6932），2025-12-02 18:04，「公告本公司第二次實施庫藏股期間屆滿及執行情形」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4744-2025-12-02-1803-1fx9acu","company_id":"4744","company":"皇將","market":"上櫃","industry":"生技醫療","date":"2025-12-02","time":"18:03:54","subject":"公告本公司接獲臺灣臺中地方法院民事判決","clause":"第2款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：皇將（4744），2025-12-02 18:03，「公告本公司接獲臺灣臺中地方法院民事判決」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2025-12-02-1801-1vzefk3","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-02","time":"18:01:58","subject":"公告本公司受邀參加宏遠證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2025-12-02 18:01，「公告本公司受邀參加宏遠證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-12-02-1734-13aa36m","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-12-02","time":"17:34:01","subject":"(補充公告)代子公司Lotus US Financing S.a.r.l.公告現金增資","clause":"第11款","fact_date":"2025-11-27","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-12-02 17:34，「(補充公告)代子公司Lotus US Financing S.a.r.l.公告現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1795-2025-12-02-1733-1esm543","company_id":"1795","company":"美時","market":"上市","industry":"生技醫療","date":"2025-12-02","time":"17:33:02","subject":"(補充公告)代盧森堡子公司Lotus US Financing S.à.r.l.公告實物增資取得有價證券","clause":"第20款","fact_date":"2025-11-27","cite_as":"公開資訊觀測站重大訊息：美時（1795），2025-12-02 17:33，「(補充公告)代盧森堡子公司Lotus US Financing S.à.r.l.公告實物增資取得有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6659-2025-12-02-1720-i845bj","company_id":"6659","company":"天明製藥","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"17:20:05","subject":"本公司細胞製備場所依「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」與中山醫學大學附設醫院合作申請細胞製備場所認可增列適應症一案，獲衛福部同意。","clause":"第9款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：天明製藥（6659），2025-12-02 17:20，「本公司細胞製備場所依「特定醫療技術檢查檢驗醫療儀器施行或使用管理辦法」與中山醫學大學附設醫院合作申請細胞製備場所認可增列」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4172-2025-12-02-1657-jy8ync","company_id":"4172","company":"因華","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"16:57:58","subject":"公告本公司現金增資發行新股申請延長募集期間經金管會核准","clause":"第44款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：因華（4172），2025-12-02 16:57，「公告本公司現金增資發行新股申請延長募集期間經金管會核准」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-12-02-1636-9dpsv1","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"16:36:21","subject":"本公司受邀參加富邦證券主辦之「2025富邦生技產業企業日」","clause":"第30款","fact_date":"2025-12-05","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-12-02 16:36，「本公司受邀參加富邦證券主辦之「2025富邦生技產業企業日」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-12-02-1629-16sohr8","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-02","time":"16:29:42","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-03","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-12-02 16:29，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2025-12-02-1610-joe5yz","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"16:10:22","subject":"公告本公司用於治療單純型遺傳性表皮分解性水皰症(EBS)之開發中新藥AC-203，獲得中國國家藥品監督管理局(NMPA)同意進行第二/三期人體臨床試驗。","clause":"第8款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2025-12-02 16:10，「公告本公司用於治療單純型遺傳性表皮分解性水皰症(EBS)之開發中新藥AC-203，獲得中國國家藥品監督管理局(NMPA)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-12-02-1538-apbzjq","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"15:38:17","subject":"代重要子公司Belite Bio, Inc公告董事會決議辦理現金增資","clause":"第9款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-12-02 15:38，「代重要子公司Belite Bio, Inc公告董事會決議辦理現金增資」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4157-2025-12-02-1520-16sohr8","company_id":"4157","company":"太景*-KY","market":"上櫃","industry":"生技醫療","date":"2025-12-02","time":"15:20:41","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-03","cite_as":"公開資訊觀測站重大訊息：太景*-KY（4157），2025-12-02 15:20，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-12-02-1511-17c4a1d","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-12-02","time":"15:11:59","subject":"代重要子公司創益生技股份有限公司公告更換股務代理機構","clause":"第53款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-12-02 15:11，「代重要子公司創益生技股份有限公司公告更換股務代理機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6931-2025-12-02-1430-14bludq","company_id":"6931","company":"青松健康","market":"上市","industry":"生技醫療","date":"2025-12-02","time":"14:30:20","subject":"公告本公司董事長訂定民國114年第三季除息基準日等相關事宜","clause":"第14款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：青松健康（6931），2025-12-02 14:30，「公告本公司董事長訂定民國114年第三季除息基準日等相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6696-2025-12-02-0706-1h5sx4t","company_id":"6696","company":"仁新*","market":"興櫃","industry":"生技醫療","date":"2025-12-02","time":"07:06:18","subject":"公告本公司召開重大訊息說明記者會之新聞稿內容","clause":"第44款","fact_date":"2025-12-02","cite_as":"公開資訊觀測站重大訊息：仁新*（6696），2025-12-02 07:06，「公告本公司召開重大訊息說明記者會之新聞稿內容」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}